B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat lymphoma: experimental drug surovatamig enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called surovatamig (AZD0486) in adults with B-cell non-Hodgkin lymphoma that has come back or stopped responding to at least two prior treatments. The goal is to see how well the drug shrinks tumors and to check for side effects. About 240 pa…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 06:25 UTC
-
Double attack on tough lymphoma: stem cell transplant plus immune cells
Disease control Recruiting nowThis study tests whether giving a special immune cell treatment (CD19 CAR-T) after a stem cell transplant can help people with hard-to-treat B-cell lymphoma. It includes 16 adults whose lymphoma has come back or not responded to standard therapy. The goal is to see if this combin…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Apr 29, 2026 06:24 UTC
-
Experimental combo therapy aims to stop lymphoma return after transplant
Disease control Recruiting nowThis early-phase study tests whether giving specially engineered immune cells (CAR T-cells) along with a vaccine can safely prevent B-cell lymphoma from coming back after a stem cell transplant. About 15 adults with aggressive or recurrent B-cell lymphoma will receive the treatme…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 06:23 UTC